Results 251 to 260 of about 1,610,894 (277)
Some of the next articles are maybe not open access.
Molecular Cancer Therapeutics, 2015
Abstract Immune checkpoint inhibitors have generated impressive clinical responses, however, a number of patients and cancer types remain resistant to checkpoint blockade. Immunosuppressive cells such as Tregs and MDSCs in the tumor microenvironment are hypothesized to mediate this resistance.
Saurabh Saha +15 more
openaire +1 more source
Abstract Immune checkpoint inhibitors have generated impressive clinical responses, however, a number of patients and cancer types remain resistant to checkpoint blockade. Immunosuppressive cells such as Tregs and MDSCs in the tumor microenvironment are hypothesized to mediate this resistance.
Saurabh Saha +15 more
openaire +1 more source
Cancer Research, 2019
Abstract Immunotherapy (IT) is trending on cancer research, but its efficacy heavily depends on the tumor microenvironment (TME). IT is also frequently combined with radiation therapy (RT). Here, we explored the effect of radiation therapy (RT) on the TME and its consequence on the combination of IT using a syngeneic orthotropic UN ...
openaire +1 more source
Abstract Immunotherapy (IT) is trending on cancer research, but its efficacy heavily depends on the tumor microenvironment (TME). IT is also frequently combined with radiation therapy (RT). Here, we explored the effect of radiation therapy (RT) on the TME and its consequence on the combination of IT using a syngeneic orthotropic UN ...
openaire +1 more source
Immune Checkpoint Inhibitors May Be Safe for Patients With Preexisting Autoimmune Disease
Ca-A Cancer Journal for Clinicians, 2020Mike Fillon
exaly
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Cell, 2017Alexandria P. Cogdill +2 more
exaly

